Israel looks to establish domestic vaccine production facility
COVID-19 accelerated the desire to explore other alternatives that may be less expensive, ensuring a steady supply of vaccines for dealing with the current epidemic as well as future epidemics.
Empty Pfizer-BioNTech coronavirus disease (COVID-19) vaccine vials for children aged 5-11 are seen in Collegeville, Pennsylvania, US, November 6, 2021.(photo credit: REUTERS/HANNAH BEIER)ByMAAYAN JAFFE-HOFFMANUpdated:
